It is a pharma public limited company based in New Delhi, Delhi, India, established in 1994.
1994 | New Delhi, Delhi, India | ActiveOasis Pharmaceuticals Limited, a active public limited company, was established on 31 January 1994 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74899DL1994PLC057156. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹3.84 Cr.
Formerly known as Oasis Pharmaceuticals Private Limited. It upholds a compliant status. Employing 1 professional, Its leadership includes Avinash Lohia (Director), Alok Narain (Director), Swati Pasari (Additional Director). Past directors included Adarsh Lohia, Avinash Lohia, Sanjay Kumar Pasari. It holds no open charges and ₹7.40 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 4239-A, 1, Ansari Road, Daryaganj,, New Delhi, Delhi, 110002.
U74899DL1994PLC057156
057156
31 January 1994
₹6.00 Cr
₹3.84 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Oasis Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Avinash Lohia | Director | 24 Apr 2017 | Current |
| Alok Narain | Director | 31 Jan 1994 | Current |
| Swati Pasari | Additional Director | 02 Dec 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Director | 24 Apr 2017 | Past |
| Pramod Abcsdd | Additional Director | 22 Sep 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 04 Aug 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oasis Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 101.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Oasis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹7,400,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Oct 1997 | Indian Overseas Bank | ₹5.00 M | Satisfied |
| 08 Oct 1997 | Indian Overseas Bank | ₹2.40 M | Satisfied |
Explore comprehensive loan charge details -
Oasis Pharmaceuticals has a workforce of 1 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Oasis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oasis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Oasis Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Oasis Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
The activity Swati Pasari was appointed as a Additional Director was appointed as a Additional Director on 02 Dec 2024 & has been associated with this company since 1 year 1 month . was completed.
The activity Avinash Lohia was appointed as a Director was appointed as a Director on 24 Apr 2017 & has been associated with this company since 8 years 8 months . was completed.
The activity A charge registered on 08 Oct 1997 via Charge ID 80027415 with Indian Overseas Bank was fully satisfied on 05 May 2008. was completed.
The activity A charge registered on 08 Oct 1997 via Charge ID 80027412 with Indian Overseas Bank was fully satisfied on 05 May 2008. was completed.
The CIN of Oasis Pharmaceuticals Limited is U74899DL1994PLC057156.
Oasis Pharmaceuticals Limited is headquartered at 4239-A, 1, Ansari Road, Daryaganj,, New Delhi, Delhi, 110002.
Oasis Pharmaceuticals Limited was incorporated on 31 January 1994.
The current directors of Oasis Pharmaceuticals Limited are
The primary industry of Oasis Pharmaceuticals Limited is Pharma.
Oasis Pharmaceuticals Limited is unlisted.
The authorized capital of Oasis Pharmaceuticals Limited is ₹6.00 Cr, and the paid-up capital is ₹3.84 Cr.
The compliance status of Oasis Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX